Transgenic rat overexpressing miR-21 in vascular smooth muscle cells:functional i
Transgenic rat overexpressing miR-21 in vascular smooth muscle cells:functional i
批准号:
8019072
负责人:
Junming Yue
金额:
$18.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-12 至 2013-11-30
关键词:
1-Phosphatidylinositol 3-Kinase3&apos Untranslated RegionsAddressAgeAnimal ModelApoptosisBCL2 geneBiologicalBiological ProcessBlood VesselsBody SizeCardiacCardiovascular DiseasesCarotid ArteriesCarotid Artery InjuriesDefectDevelopmentDiagnosisDiseaseExhibitsFunctional RNAGene ExpressionGenesGrantGrowthHeart HypertrophyHereditary DiseaseHumanHyperplasiaHypertrophyInjuryKnockout MiceLentivirus VectorLimb structureMalignant NeoplasmsMessenger RNAMethodsMicroRNAsMicroscopicMitogen-Activated Protein KinasesModelingMolecularMusOncogenicPTEN geneParalysedPathway interactionsPhenotypePhysiologicalPlayProteinsProto-Oncogene Proteins c-aktPulmonary HypertensionRattusRegulationReportingRoleSignal PathwaySignal TransductionSmall RNASmooth MuscleSmooth Muscle MyocytesTestingTransgenic OrganismsTranslationsVascular DiseasesVirus Diseasesbasecardiovascular disorder therapyinjuredinsightmolecular phenotypemouse modelneointima formationoverexpressionpromoterpublic health relevancetransgene expression
中文摘要
描述(由申请人提供):微小RNA(miRNA)是一类新的非编码小RNA,其通过降解mRNA或抑制蛋白质翻译来负调节基因表达。研究表明,miRNA在多种疾病中发挥着非常重要的作用,例如癌症、病毒感染、遗传性疾病和心血管疾病。最近我们发现miR-21是一种致癌的miRNA基因,在多种癌症中异常过表达,在小鼠心肌肥厚模型和大鼠颈动脉球囊损伤模型中也上调。通过靶向磷酸酶和张力蛋白同源物(PTEN)基因的3 '非翻译区(UTR)并间接调节血管平滑肌细胞(VSMC)中Bcl-2基因的表达,敲低miR-21诱导血管平滑肌细胞和大鼠颈动脉球囊损伤模型中的凋亡。为了进一步了解miR-21调控血管疾病中重要信号通路基因表达的分子机制,我们构建了一个由大鼠平滑肌细胞特异性启动子(rSM22)驱动的miR-21基因慢病毒载体,并建立了一个在VSMCs中过表达miR-21的转基因大鼠模型。我们发现,几个转基因大鼠创始人表现出一致的表型:生长迟缓和轻微瘫痪的后肢。这种转基因大鼠模型将为理解miRNA在心血管疾病中的功能提供新的思路,并将帮助我们进一步评估miRNA在诊断和测试基于miRNA的心血管疾病治疗中的潜在应用。
公共卫生相关性:本研究拟利用慢病毒载体构建表达miR-21的转基因大鼠模型,通过靶向miR-21基因进入血管平滑肌细胞,研究miR-21的生物学功能。通过研究miR-21如何参与转录后调控,还将使用该转基因大鼠模型检查表型和表型背后的分子机制。
英文摘要
DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are a new class of non-coding small RNAs that negatively regulate gene expression by either degrading mRNA or inhibiting protein translation. miRNAs have been shown to play very important roles in a variety of diseases, such as cancers, viral infection, genetic disorders, and cardiovascular diseases. Recently we found that miR-21, an oncogenic miRNA gene was aberrantly overexpressed in a variety of cancers, was also upregulated in the mouse cardiac hypertrophy model and rat carotid artery balloon injury model. Knockdown of miR-21 induced apoptosis in vascular smooth muscle cells and in the rat carotid artery balloon-injured model by targeting the 3'untranslated region (UTR) of the phosphatase and tensin homolog (PTEN) gene and indirectly regulated Bcl-2 gene expression in vascular smooth muscle cells (VSMCs). To further understand the molecular mechanism by which miR-21 regulates gene expression on the important signaling pathways, which play pivotal roles in vascular diseases, we constructed a lentiviral vector in which the miR-21 gene was driven by the rat smooth muscle cell specific promoter (rSM22) and generated a transgenic rat model in which miR-21 is overexpressed in VSMCs. We found that several transgenic rat founders display consistent phenotypes: growth retardation and slightly paralyzed hind limbs. This transgenic rat model will certainly provide insight to understanding miRNA functions in cardiovascular diseases and will help us further evaluate potential applications of miRNA in diagnosing and test miRNA based therapy for cardiovascular diseases.
PUBLIC HEALTH RELEVANCE: This proposal is to characterize transgenic rats expressing miR-21 using lentiviral vector to address the biological functions of miRNAs by targeting miR-21 gene into vascular smooth muscle cells. The phenotype and molecular mechanisms underlying the phenotypes will also be examined using this transgenic rat models by investigating how miR-21 is involved in the posttranscriptional regulation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0130341
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Wang Y, Yang C, Gu Q, Sims M, Gu W, Pfeffer LM, Yue J]
通讯作者:
Yue J
Role of MTF1 in ovarian cancer
-
批准号:9587594
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2018
-
负责人:Junming Yue
-
依托单位:
Role of MTF1 in ovarian cancer
-
批准号:9750254
-
项目类别:
-
资助金额:$17.23万
-
财政年份:2018
-
负责人:Junming Yue
-
依托单位:
Transgenic rat overexpressing miR-21 in vascular smooth muscle cells:functional i
-
批准号:7789816
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2010
-
负责人:Junming Yue
-
依托单位:
Transgenic rat overexpressing miR-15/16 cluster:functional implications in develo
-
批准号:7701252
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2009
-
负责人:Junming Yue
-
依托单位:
Transgenic rat overexpressing miR-15/16 cluster:functional implications in develo
-
批准号:7929580
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2009
-
负责人:Junming Yue
-
依托单位:
国内基金
登录
查看更多内容
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
-
批准号:81300507
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:陈黎
-
依托单位:
3'-甲氧基葛根素生物合成途径中关键甲基转移酶基因的克隆与功能分析
-
批准号:31300258
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:黎佳
-
依托单位:
3'-UTR单核苷酸多态性影响CYP8B1基因表达致胆囊胆固醇结石形成的机制研究
-
批准号:81370561
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:秦俭
-
依托单位:
异源杂交多倍化鲫鲤特有性状的转录组及后转录组水平变化规律研究
-
批准号:31360514
-
项目类别:地区科学基金项目
-
资助金额:54.0万元
-
批准年份:2013
-
负责人:罗静
-
依托单位:
HIF基因3'UTR区SNP参与胰腺癌HIF-1α表达调控的分子机制及功能研究
-
批准号:81302082
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王秀超
-
依托单位:
鼻咽癌转移相关通路分子的microRNA调控机制及3'UTR区可变剪切的作用研究
-
批准号:81372886
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:买世娟
-
依托单位:
小鼠精原干细胞中APA位点研究及3'UTR使用频率数据库构建
-
批准号:31301085
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2013
-
负责人:熊远妍
-
依托单位: